Cargando…
Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in pri...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661395/ https://www.ncbi.nlm.nih.gov/pubmed/29118761 http://dx.doi.org/10.3389/fimmu.2017.01391 |
_version_ | 1783274474374692864 |
---|---|
author | Saresella, Marina Mendozzi, Laura Rossi, Valentina Mazzali, Franca Piancone, Federica LaRosa, Francesca Marventano, Ivana Caputo, Domenico Felis, Giovanna E. Clerici, Mario |
author_facet | Saresella, Marina Mendozzi, Laura Rossi, Valentina Mazzali, Franca Piancone, Federica LaRosa, Francesca Marventano, Ivana Caputo, Domenico Felis, Giovanna E. Clerici, Mario |
author_sort | Saresella, Marina |
collection | PubMed |
description | Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in principle, result in immune modulation and, thus, could be used to obtain beneficial outcomes for patients. We verified this hypothesis in a pilot study involving two groups of clinically similar relapsing-remitting (RR) MS patients who had undergone either a high-vegetable/low-protein diet (HV/LP diet group; N = 10) or a “Western Diet” (WD group; N = 10) for at least 12 months. Gut microbiota composition, analyzed by 16 S V4 rRNA gene sequencing and immunological profiles, was examined after a minimum of 12 months of diet. Results showed that, in the HV/LP diet group compared to the WD group: (1) Lachnospiraceae family was significantly more abundant; (2) IL-17-producing T CD4+ lymphocytes (p = 0.04) and PD-1 expressing T CD4+ lymphocytes (p = 0.0004) were significantly decreased; and (3) PD-L1 expressing monocytes (p = 0.009) were significantly increased. In the HV/LP diet group, positive correlations between Lachnospiraceae and both CD14+/IL-10+ and CD14+/TGFβ+monocytes (R(Sp) = 0.707, p = 0.05, and R(Sp) = 0.73, p = 0.04, respectively), as well as between Lachnospiraceae and CD4+/CD25+/FoxP3+ T lymphocytes (R(Sp) = 0.68, p = 0.02) were observed. Evaluation of clinical parameters showed that in the HV/LP diet group alone the relapse rate during the 12 months follow-up period and the Expanded Disability Status Scale score at the end of the study period were significantly reduced. Diet modulates dysbiosis and improves clinical parameters in MS patients by increasing anti-inflammatory circuits. Because Lachnospiraceae favor Treg differentiation as well as TGFβ and IL-10 production this effect could be associated with an increase of these bacteria in the microbiota. |
format | Online Article Text |
id | pubmed-5661395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56613952017-11-08 Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study Saresella, Marina Mendozzi, Laura Rossi, Valentina Mazzali, Franca Piancone, Federica LaRosa, Francesca Marventano, Ivana Caputo, Domenico Felis, Giovanna E. Clerici, Mario Front Immunol Immunology Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in principle, result in immune modulation and, thus, could be used to obtain beneficial outcomes for patients. We verified this hypothesis in a pilot study involving two groups of clinically similar relapsing-remitting (RR) MS patients who had undergone either a high-vegetable/low-protein diet (HV/LP diet group; N = 10) or a “Western Diet” (WD group; N = 10) for at least 12 months. Gut microbiota composition, analyzed by 16 S V4 rRNA gene sequencing and immunological profiles, was examined after a minimum of 12 months of diet. Results showed that, in the HV/LP diet group compared to the WD group: (1) Lachnospiraceae family was significantly more abundant; (2) IL-17-producing T CD4+ lymphocytes (p = 0.04) and PD-1 expressing T CD4+ lymphocytes (p = 0.0004) were significantly decreased; and (3) PD-L1 expressing monocytes (p = 0.009) were significantly increased. In the HV/LP diet group, positive correlations between Lachnospiraceae and both CD14+/IL-10+ and CD14+/TGFβ+monocytes (R(Sp) = 0.707, p = 0.05, and R(Sp) = 0.73, p = 0.04, respectively), as well as between Lachnospiraceae and CD4+/CD25+/FoxP3+ T lymphocytes (R(Sp) = 0.68, p = 0.02) were observed. Evaluation of clinical parameters showed that in the HV/LP diet group alone the relapse rate during the 12 months follow-up period and the Expanded Disability Status Scale score at the end of the study period were significantly reduced. Diet modulates dysbiosis and improves clinical parameters in MS patients by increasing anti-inflammatory circuits. Because Lachnospiraceae favor Treg differentiation as well as TGFβ and IL-10 production this effect could be associated with an increase of these bacteria in the microbiota. Frontiers Media S.A. 2017-10-25 /pmc/articles/PMC5661395/ /pubmed/29118761 http://dx.doi.org/10.3389/fimmu.2017.01391 Text en Copyright © 2017 Saresella, Mendozzi, Rossi, Mazzali, Piancone, LaRosa, Marventano, Caputo, Felis and Clerici. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Saresella, Marina Mendozzi, Laura Rossi, Valentina Mazzali, Franca Piancone, Federica LaRosa, Francesca Marventano, Ivana Caputo, Domenico Felis, Giovanna E. Clerici, Mario Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title | Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title_full | Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title_fullStr | Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title_full_unstemmed | Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title_short | Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study |
title_sort | immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661395/ https://www.ncbi.nlm.nih.gov/pubmed/29118761 http://dx.doi.org/10.3389/fimmu.2017.01391 |
work_keys_str_mv | AT saresellamarina immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT mendozzilaura immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT rossivalentina immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT mazzalifranca immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT pianconefederica immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT larosafrancesca immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT marventanoivana immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT caputodomenico immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT felisgiovannae immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy AT clericimario immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy |